Retatrutide works as a powerful triple-agonist, meaning it works on on three key hormone receptors: The human glucagon receptor (GCGR) The glucose-dependent polypeptide receptor (GIP receptor) The glucagon-like peptide-1 receptor (GLP-1) This unique receptor profile allows retatrutide to effectively: Regulate appetite, feelings of fullness, and gastric emptying Regulate metabolism Regulate blood sugar levels The activation of the GIP, GLP-1, and GCG receptors simultaneously by retatrutide leads to better weight loss and cardiometabolic benefits compared to targeting a single receptor
Storage: Cool, dry place after opening
Every form of exercise counts while on GLP1-s
However, the FDA continues to monitor for these effects through post-marketing surveillance
as I write this, that video has over 150,000 likes, 22,000 bookmarks, and has been shared 1,500 times
Ferroptosis, a new form of cell death: Opportunities and challenges in cancer